Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents.

@article{Badiee2011SusceptibilityOC,
  title={Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents.},
  author={Parisa Badiee and Abdolvahab Alborzi and Elaheh Shakiba and Shohreh Farshad and Aziz Japoni},
  journal={Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit},
  year={2011},
  volume={17 5},
  pages={
          425-30
        }
}
  • P. Badiee, A. Alborzi, +2 authors A. Japoni
  • Published 1 May 2011
  • Medicine
  • Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
This study was carried out from October 2003 to March 2007 to investigated susceptibility patterns ot March 2007 to antifungals of Candida strains isolated from 410 immunocompromised patients in Shiraz, Islamic Republic of Iran. Patients were checked for systemic candidiasis. Fungal colonization was determined and clinical samples collected from those patients with clinical signs of infections were examined. The carbohydrate assimilation patterns of all 354 isolates were studied. Susceptibility… Expand
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran
TLDR
The findings suggest that the susceptibility patterns of Candida species (colonizing and infecting isolates) in immunocompromised patients are not the same and acquired resistance was seen in some species. Expand
Antifungal susceptibility patterns of colonized Candida species isolates from immunocompromised pediatric patients in five university hospitals
TLDR
C. albicans was the most prevalent species in pediatric colonized patients and new azole agents like voriconazole and posaconazole are effective against non-albicans Candida species. Expand
Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital
TLDR
Isolates from vagina and burned patients had the highest resistance rate, while all of the isolates from ascites and dermatological services were susceptible to fluconazole. Expand
Susceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents
TLDR
Fluconazole is the drug of choice for management of patients at risk for systemic candidiasis throughout the region, since it is cost-effective with low side effects. Expand
Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Clinical Samples
TLDR
C. albicans is the most prevalent etiologic agent in infected patients and caspofungin is themost effective antifungal agent. Expand
Candida non albicans with a High amphotericin B resistance pattern causing candidemia among cancer patients.
TLDR
High resistance to amphotricin B was observed among all the Candida non-albicans isolates and regular investigations into antifungal resistance will help the physician in selecting the antibiotics for empirical therapy. Expand
Susceptibility pattern of anti-candida drugs in the pediatric patients with acute leukemia
TLDR
In this study, caspofungin was the most effective antifungal agent against the colonized Candida spp. Expand
Yeast Colonization and Drug Susceptibility Pattern in the Pediatric Patients With Neutropenia
TLDR
In this study, caspofungin was the most effective antifungal agent against the colonized Candida spp. Expand
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates
TLDR
The findings suggest that the susceptibility patterns of Candida species (colonizing and infecting isolates) in immunocompromised patients are not the same and acquired resistance was seen in some species. Expand
Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study
Background and Objectives The incidence of fungal infections in immunocompromised patients, especially by Candida species, has increased in recent years. This study was designed to identify CandidaExpand
...
1
2
3
4
...

References

SHOWING 1-10 OF 18 REFERENCES
Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals.
TLDR
This study provides important baseline data as the isolates were collected prior to fluconazole being made freely available to HIV/AIDS patients attending government health clinics, and very little difference was observed in the antifungal profile between the South African isolates and isolates from the United States, Canada and South America. Expand
In Vitro Activities of Isavuconazole and Other Antifungal Agents against Candida Bloodstream Isolates
TLDR
Isavuconazole was more active than itraconazole and voriconazole against C. albicans and C. glabrata and appears to be a promising agent against systemic Candida infections. Expand
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
  • O. Marchetti, J. Billé, +7 authors D. Pittet
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
TLDR
Despite increasing high-risk activities, the incidence of candidemia remained unchanged, and no shift to resistant species occurred, in Switzerland during 1991-2000. Expand
Changing spectrum of invasive candidiasis and its therapeutic implications.
  • N. Singh
  • Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2001
TLDR
Emerging trends in invasive candidiasis are notable for a dramatic increase in infections due to non-albicans Candida species, and these evolving trends have far-reaching clinical relevance. Expand
Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies.
TLDR
Prescription policies likely to favour or limit fluconazole resistance within a clinical department are identified, and restoration of a normal ecology was observed when low-dose prolonged or intermittent prescriptions were reduced. Expand
Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation
TLDR
The goal of this study was to track the development of increased fluconazole resistance in C. glabrata and to evaluate previously described genetic mechanisms associated with this resistance from one of these three patients. Expand
Treatment options of invasive fungal infections in adults.
TLDR
Treatment guidelines for invasive aspergillosis (IA) were stratified into primary therapy, salvage therapy and combination therapy in critically ill patients, and amphotericin B deoxycholate is recommended as initial therapy for the empirical therapy in patients with neutropenia and persistent fever. Expand
Fluconazole and Voriconazole Multidisk Testing ofCandida Species for Disk Test Calibration and MIC Estimation
TLDR
The results show that disk diffusion methods might be useful for azole testing of Candida isolates and there was a significant correlation between the two measurements. Expand
Antifungal susceptibility testing.
TLDR
A standard method which minimizes interlaboratory variability during the testing of Candida spp. Expand
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
TLDR
Posaconazole exhibited potent antifungal activity against a wide variety of clinically important fungal pathogens and was frequently more active than other azoles and amphotericin B. Expand
...
1
2
...